alexa Efficacy of Spirulina (Tahlab) in Patients of Type 2 Diabetes Mellitus (Ziabetus Shakri) - A Randomized Controlled Trial
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Efficacy of Spirulina (Tahlab) in Patients of Type 2 Diabetes Mellitus (Ziabetus Shakri) - A Randomized Controlled Trial

Anzar Alam1*, Siddiqui MA2, Aleemuddin Quamri2, Sana Fatima3, Mariyam Roqaiya4 and Zaheer Ahmad5

1Department of Moalajat, Luqman Unani Medical College Hospital and Research Centre, Bijapur, Karnataka, India

2Department of Moalajat, National Institute of Unani Medicine, Kottigepalya, Bengaluru, Karnataka, India

3Department of Pharmacy, National Institute of Unani Medicine, Kottigepalya, Bengaluru, Karnataka, India

4Department of Ilmul Qabala wa Amraze Niswan, Luqman Unani Medical College Hospital and Research Centre, Bijapur, Karnataka, India

5Research Officer (Unani) S-4, RRIUM, Chennai, India

*Corresponding Author:
Dr. Anzar Alam
Assistant Professor, Department of Moalajat
Luqman Unani Medical College
12 Naubag, Bijapur, Karnataka, India
Tel: +91-9902146030
E-mail: [email protected]

Received date: August 22, 2016; Accepted date: October 18, 2016; Published date: October 25, 2016

Citation: Alam A, Quamri S, Fatima S, Roqaiya M, Ahmad Z (2016) Efficacy of Spirulina (Tahlab) in Patients of Type 2 Diabetes Mellitus (Ziabetus Shakri) - A Randomized Controlled Trial. J Diabetes Metab 7:710. doi: 10.4172/2155-6156.1000710

Copyright: © 2016 Alam A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Aims: Diabetes mellitus (DM) (Ziabetus Shakri) is a common metabolic disease affecting 150,000,000 people worldwide. Despite the recent advancements in management of Diabetes its relative co-morbidities and mortality is ever increasing globally. Unani scholars had claimed the effectiveness of several anti-diabetic drugs in the classical texts in the management of DM, but it lacks scientific documentation. Hence, a clinical trial was contemplated to evaluate the efficacy of test drug Tahlab (Spirulina) in patients of type 2 DM.
Methods: The study was a single blind randomized standard control conducted on 40 patients of type 2 DM. 30 subjects were allocated to test and 10 to control group. Test group received 7 grams of Tahlab powder twice a day, and control group received Metformin (500 mg) 1 tablet twice a day for a period of 45 days. Subjective and objective parameters were assessed at 0, 15th, 30th, 45th day.
Results: The Mean score for FBS in test group has declined from 245.53 to 204.87 and PPBS from 345.73 to 303.67 respectively. The Mean score for FBS in control group has declined from 227.60 to 191.80 and PPBS from 329.60 to 282.80 respectively. Intergroup comparison revealed test drug to be similar to that of control drug in reducing FBS and PPBS. HbA1c and urine sugar remained unaltered in both groups. The results were assessed statistically using two tailed student t test, paired proportion test and Fischer exact test.
Conclusions: The study revealed that the test drug is safe and equally effective when compared to control drug.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords